FindTrial
Sign In

Do Thyroid Antibodies Affect IVF-ICSI Pregnancy Chances? A Study in Women Undergoing Treatment

The impact of Anti-thyroid peroxidase (Anti-TPO) and anti-thyroglobulin (Anti-TG) antibodies on pregnancy outcomes in women undergoing in vitro fertilization (IVF-ICSI) cycles - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086679
Enrollment
672
Registered
2025-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Aparna Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Undergoing controlled ovarian stimulation for IVF, with known thyroid antibody status

Exclusion criteria

Exclusion criteria: History of thyroidectomy, untreated thyroid disorders, other autoimmune diseases

Design outcomes

Primary

MeasureTime frame
IVF success rates, including implantation, clinical pregnancy, and live birth ratesTimepoint: Till Delivery—

Secondary

MeasureTime frame
To evaluate the effect of anti-TPO and anti-TG antibodies on embryo quality and fertilization rates. To determine whether thyroid autoimmunity influences miscarriage rates and pregnancy complications in IVF patients. To explore potential interventions to improve pregnancy outcomes in IVF patients with thyroid autoimmunity.Timepoint: Till delivery—

Countries

India

Contacts

Public ContactDr Aparna Das

A4 Hospitals and Fertility centre Pvt Ltd

aparna@a4fertility.com09791803444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026